Intracellular protein delivery is an important tool for both therapeutic and fundamental applications. Effective protein delivery faces two major challenges: efficient cellular uptake and avoiding endosomal sequestration. We report here a general strategy for direct delivery of functional proteins to the cytosol using nanoparticle-stabilized capsules (NPSCs). These NPSCs are formed and stabilized through supramolecular interactions between the nanoparticle, the protein cargo, and the fatty acid capsule interior. The NPSCs are ~130 nm in diameter and feature low toxicity and excellent stability in serum. The effectiveness of these NPSCs as therapeutic protein carriers was demonstrated through the delivery of fully functional caspase-3 to HeLa cells with concomitant apoptosis. Analogous delivery of green fluorescent protein (GFP) confirmed cytosolic delivery as well as intracellular targeting of the delivered protein, demonstrating the utility of the system for both therapeutic and imaging applications.
Mechanical delivery methods, such as microinjection and electroporation have been used in research for decades. 13 These methods, however, are low-throughput, disruptive, and require specialized equipments to mechanically/physically puncture membranes, limiting their utility for in vivo applications. Another promising approach for delivering proteins utilizes covalent carriers 14, 15 that require irreversible modifications of the protein cargo. 16, 17 However, these covalent modifications of protein may impact protein function by interfering with protein folding. 18, 19 Furthermore, covalent modification of proteins for delivery is not a general approach; in cases where this strategy works customized optimization protocols tailored to each specific protein are required. 14 A major challenge in all the non-mechanical protein delivery strategies described above is access of the protein to the cytosol. Most delivery strategies rely on endocytic mechanisms of cellular uptake. 20 As a result, the delivered proteins are susceptible to degradation in the endosome/lysosome and are also unable to access key subcellular structures and machineries required for most applications. 15 Currently, prolonged incubation times, elevated concentrations of delivery agents, and lysosomotropic reagents (such as chloroquine) are required to increase the efficiency of endosomal escape of delivered proteins. 21, 22 Supramolecular carrier-based delivery methods are modular, easy to formulate, and operate through reversible associations with target proteins. 23 In non-covalent strategies, proteins and delivery vectors self-assemble, allowing the transport of unmodified proteins into the cell and overcome the limitations of using covalently protein modification strategies. 14, 15 We have recently developed a nanoparticle-stabilized capsule (NPSC) system for the delivery of hydrophobic drugs. 24 These NPSCs rapidly released small molecule payloads from their oil interior through a membrane fusion-like 25, 26 hydrophobic interaction with the cell membrane. We hypothesized that this vehicle could also be used for cytosolic protein delivery by incorporating functional proteins into the NPSC shell. In this report, we demonstrate rapid and efficient delivery of therapeutic and imaging proteins into the cytosol of HeLa cells using NPSCs. Caspase-3 (CASP3) was chosen to demonstrate therapeutic delivery of an active, biomedically important enzyme. Delivery of CASP3 is a particularly stringent test of the efficacy of this approach, as caspases are delicate enzymes that would be susceptible to inactivation during the delivery process. CASP3 was efficiently delivered into cells, resulting in effective induction of apoptosis. Green fluorescent protein (GFP) was used to determine the intracellular distribution of delivered proteins. The delivered GFP was distributed throughout the cell with identical cellular distribution to that of endogenously expressed red fluorescent protein (RFP). Further proof of cytosolic access was demonstrated through efficient intracellular targeting of a GFP fusion protein to the peroxisome. 27 
RESULTS AND DISCUSSION

Nanoparticle-stabilized capsule fabrication
The protein-NPSC (CASP3-NPSC and GFP-NPSC) complexes were generated using a convergent process (Figure 1a , see Methods), where the HKRK AuNPs (see Figure 1a for the structure) provided a dual mode supramolecular stabilization of the capsule wall. Briefly, proteins and AuNPs were mixed and incubated at room temperature for 10 minutes. Template emulsions were formed by homogenizing AuNPs in phosphate buffer (5 mM, pH 7.4) and oil. Protein-NPSCs were formed by combining template emulsions and the protein-AuNP mixture. Combined hydrogen bonding and electrostatic interactions between the guanidinium moieties of the particles and the carboxylates of the oil 28, 29 pin the nanoparticles to the capsule surface. Lateral stabilization is provided through interactions of the cationic nanoparticles with the anionic proteins (GFP pI= 5.9, CASP3 pI= 6.1) to be transported (Figure 1a ). 30 The capsule size is well-controlled and in a regime well suited for intracellular delivery 31 with GFP-NPSCs and CASP3-NPSCs possessing average diameters as determined by dynamic light scattering of 130 ± 40 nm and 140 ± 20 nm, respectively ( Figure 1b and c, Figure S1 ).
A fluorescence titration was performed to measure the binding constant (K s ) between HKRK AuNPs and GFP, which was found to be 9 × 10 7 M −1 , indicating high affinity of HKRK AuNPs to the protein ( Figure S2a ). Screening of the electrostatic interactions through the use of 500 mM NaCl into the mixture of AuNPs with GFP at 1:1 molar ratio resulted in complete recovery of the GFP fluorescence ( Figure S2b ), indicating reversible electrostatic interactions between the HKRK AuNP and the protein. GFP is almost completely quenched upon complexation by AuNPs. NPSC formation, however, results in a partial restoration in fluorescence. This result indicates a change in the structure of GFP-AuNP complex when at the interface of the NPSCs. To further probe the nature of the interactions, the NPSCs were incubated in 0.5% Tween-20 and 500 mM NaCl solutions. The high salt solution resulted in no change in fluorescence, while Tween-20 resulted in increased in fluorescence. (79%; Figure S3 ). These results suggest that other interactions are involved in NPSC assembly beyond simple electrostatics. For CASP3, enzyme activity was assessed after interaction with HKRK AuNPs. Activity assays in vitro showed that the interaction between CASP3 and HKRK AuNPs did not inhibit the enzymatic activity. In fact, HKRK AuNPs enhanced the CASP3 activity by 2.3 times, a phenomenon observed previously in other nanoparticle-protein systems 32 ( Figure S4 ). While efforts were made to assess activity of CASP3 in the NPSCS, the biphasic nature of the system prevented effective measurement of catalytic efficiency.
Therapeutic protein delivery with NPSCs
Effective use of therapeutic proteins for intracellular applications requires rapid delivery of the protein in the active form to the cytosol. 33, 34 CASP3 is a highly promising therapeutic protein candidate 35 owing to its critical role in apoptosis. 36 Most tumor cells do not undergo appropriate apoptosis, which leads to unhindered cell growth. 37 In many tumor cells CASP3 function is blocked due to over expression of inhibitor of apoptosis (IAP) proteins that directly inhibit caspase function preventing apoptosis. Intracellular delivery of sufficient levels of active CASP3 into the cytosol of such tumor cells circumvents this blockage, allowing tumor cells to enter apoptosis. Delivery of active caspases is extremely challenging, however, due to the negative charge and heterotertrameric state of the protein, the susceptibility of the active site to oxidation and alkylation, and the fragile nature of the active site that is composed of four highly mobile loops.
Demonstration of effective delivery of active CASP3 was established through incubation of HeLa cells with CASP3-NPSCs. After 1 h incubation, 72.0 ± 5.5% of HeLa cells underwent apoptosis, confirmed by double staining with Yopro-1 (a dye to detect apoptotic cell nuclei) 38 and 7-AAD (a dye used to detect membrane disruption) 39 (Figure 2a ). The NPSC itself (Figure 2b ), CASP3 only (Figure 2c ), or CASP3 with AuNPs ( Figure S5d) induced minimal levels of cell apoptosis, demonstrating that CASP3-NPSCs deliver the protein in the active form required for therapeutic applications.
GFP delivery using NPSCs
The effectiveness of the delivered caspase suggested access of the delivered protein to the cytosol. The capability of cytosolic delivery of NPSCs was verified using GFP. Imaging experiments were performed using live cells to provide an accurate determination of protein distribution inside the cell. 40 After 1 h incubation of GFP-NPSCs with HeLa cells, followed by 1 h incubation in fresh media, GFP was observed evenly distributed throughout the cytosol and nucleus (Figure 3a) . In comparison, no delivery was observed by mixing empty NPSCs and GFP, indicating that the NPSCs serve as a carrier for the delivery cargo and not solely as a "hole puncher" for membrane penetration ( Figure S6 ). To further demonstrate the cytosolic distribution of GFP, NPSCs were used to deliver GFP into mCherry expressing HeLa cells. 41 Confocal images (Figure 3b and Figure S7) show GFP delivered via NPSCs to be evenly distributed throughout the cytosol and nucleus (with the exception of nucleoli) of HeLa cells, with no perceptible difference in distribution with respect to mCherry. Coadministration of Hoechst 33342 (a family of blue fluorescent dyes used to stain nuclei) confirmed that the delivered GFP had gained access to the nucleus, but not to the interiors of nucleoli ( Figure S6) , consistent with the distribution of cellularly expressed mCherry. Dispersal of GFP in the nucleus indicated that GFP was successfully delivered not just to the cytosol, but also to the nucleus by free diffusion through nuclear pores. 42 Taken together, these results demonstrate that the GFP was successfully delivered into the cytosol in a freely diffusing fashion.
Flow cytometry was used to quantify the efficiency of GFP delivery into cells using NPSCs. The results showed that GFP was delivered to 77 ± 5% of cells in the GFP-NPSCs group (Figure 3c) , consistent with the apoptosis induction observed with the CASP3-NPSCs. As expected, no delivery was observed for either the cells treated with GFP alone or untreated. Only low levels of delivery (20.6 ± 3.8%) were observed for GFP-HKRK AuNP complexes that were not in capsule form ( Figure S9) , with most of the delivered GFP remaining entrapped in late endosomes/lysosomes ( Figure S10) . The difference in GFP delivery efficiency and subcellular localization between the particle-only group and the NPSC group supports the hypothesis that the improved efficiency of the delivery process in the NPSC group resulted from a membrane fusion-delivery process, in agreement with previous studies. 24, 43, 44 The NPSCs showed little cytotoxicity at the concentration (29 pM) used for the delivery studies ( Figure S11 ).
Live cell video imaging was then performed to track the intracellular release of protein payloads by NPSCs (Figure 4 and Movies S1, S2). As shown in Figure 4 and Movie S1, GFP-NPSCs remain intact for the first few minutes after attaching to the cell, confirmed by the colocalization of GFP and the AuNPs. Then GFP was rapidly released into cytosol within. As seen from Movie S2, GFP was rapidly delivered, however the GFP-NPSC was not taken up as an intact entity by the cell. Taken together, these results strongly support the membrane fusion mechanism of delivery while demonstrating that uptake does not occur through an endocytotic mechanism
Intracellular targeting of delivered proteins
To further demonstrate the versatility of NPSC protein delivery for intracellular delivery and imaging, we fused a peroxisomal-targeting sequence 1 (PTS1) to GFP ( Figure S12 ). 45 HeLa cells with stable expression of RFP bearing a C-terminal peroxisomal-targeting sequence were used to provide a fluorescence label for the peroxisomes. After 1 h incubation with GFP-PTS1-NPSC complexes, followed by 1 h incubation with fresh media, the confocal images clearly confirmed complete colocalization of the GFP-PTS1 fusion protein with the RFP-labeled peroxisomes (Figure 5a and Figure S13 ). In contrast, GFP without the PTS1 motif was evenly distributed throughout the cell as previously described (Figure 5b) . These results clearly demonstrate that the protein delivered by the NPSCs gained complete access to the cytosol, and that proteins delivered by NPSCs are capable of targeting subcellular organelles with essentially identical localization behavior to cellularly expressed proteins. 27
CONCLUSION
We have demonstrated a rapid and efficient protein delivery strategy using nanoparticle based supramolecular nanocapsules. This approach provides a generalized strategy for direct delivery of functional proteins in their native forms. The supramolecular structure of the NPSCs makes the system stable for delivery of proteins yet reversible for payload release. In contrast with particle based protein delivery systems, this method is capable of overcoming the major challenge of endosomal sequestration and thus holds great promise for effective protein therapy and imaging applications. We demonstrated the efficiency of the system by delivering a functional therapeutic protein, CASP3 into target cells to induce apoptosis. Delivery of fluorescent proteins demonstrated cytosolic distribution identical to that of a cellularly expressed counterpart, with delivery versatility further demonstrated by subcellular targeting of proteins. Taken together, the ability to incorporate active proteins on the capsule shell and efficiently deliver into the cytosol opens up new opportunities for protein replacement therapy, in vivo disease prognosis through imaging, cellular organelle labeling, and cellular engineering.
METHODS
Protein-NPSC complex preparation
The HKRK ligand protected AuNPs (HKRK AuNPs) were synthesized following reported method. 30 To make the protein-NPSC complex, 2.5 μM HKRK AuNPs were incubated with 1 μM GFP in 30 μL phosphate buffer (5 mM, pH = 7.4) for 10 min. Then, 1 μL of the mixture of linoleic acid and decanoic acid (molar ratio = 1:1) was mixed with 500 μL of phosphate buffer (5 mM, pH = 7.4) containing 1 μM HKRK AuNPs and agitated by an amalgamator at 5000 rpm for 100 s to form emulsions. Finally, the mixture of the protein and HKRK AuNPs was diluted to 45 μL with phosphate buffer (5 mM, pH = 7.4) followed by the addition of 5 μL of the emulsion. The protein-NPSC complexes were ready to use after 10 min incubation at room temperature. The concentration of NPSC was 0.29 nM, calculated according to reported method. 24 The final concentrations of HKRK AuNPs and GFP were 1.5 μM and 600 nM, respectively.
GFP delivery
60,000 or 240,000 HeLa cells or transfected HeLa cells were cultured in a 24-well plate or confocal dish, respectively, for 24 h prior to delivery. The cells were washed by cold phosphate buffer saline (PBS) 3 times right before delivery. After the preparation of cells, GFP-NPSC complex solution (50 μL or 150 μL of the GFP-NPSC complex diluted by 450 μL or 1.35 mL of the DMEM without FBS, respectively) was incubated with the cells for 1 h in a 24-well plate or confocal dish, and followed by incubation with fresh DMEM with 10% FBS for 1h unless otherwise mentioned. To study the colocalization with Hoescht 33342 or Lysotracker, the reagent was introduced 20 min before the observation.
CASP3 delivery
The procedure of CASP3 delivery was similar to that of GFP delivery, except that 30,000 HeLa cells were incubated in a 24-well plate for 24 h prior to delivery. After the protein delivery, the cells were stained by Yopro-1 and 7-AAD for 30 min, followed by the observation under fluorescence microscope. The apoptotic ratio of each sample was calculated as the ratio of fluorescently stained cells over total 100 cells.
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Refer to Web version on PubMed Central for supplementary material. Delivery of caspase-3 into HeLa cells. Cells were incubated for 1 h with (a) CASP3-NPSC, (b) NPSC without CASP3, and (c) only CASP3 without NPSC. Subsequently, cells were stained using Yopro-1 (green fluorescence) and 7-AAD (red fluorescence) for 30 min, and the overlapped images are presented as apoptotic. Individual channel images are shown in Figure S5 . (d) Apoptosis ratios of the cells after CASP3 delivery. Scale bars: 100 μm; the error bars represent the standard deviations of three parallel measurements. 
